{"disease":{"id":"iron","name":"iron"},"drugs":{"marketed":[{"drug_id":"ferrous-fumarate","indication_name":"Iron Deficiency Anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iron Fumarate","generic_name":"FERROUS FUMARATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"ferrous-fumarate","indication_name":"Iron Deficiency in Pregnancy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iron Fumarate","generic_name":"FERROUS FUMARATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"sucrose","indication_name":"Iron Deficiency Anemia in CKD on Hemodialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SUCROSE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Parenteral Iron Replacement [EPC]","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"ferric-oxide","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iron Oxide","generic_name":"ferric oxide","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"ferrous-fumarate","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iron Fumarate","generic_name":"FERROUS FUMARATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"exjade","indication_name":"Chronic Iron Overload","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Exjade","company_name":"DisperSol Technologies, LLC","drug_phase":"marketed","molecular_target":"Flavin reductase (NADPH), Lysine-specific demethylase 5A","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"ferrous-sulfate","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FERROUS SULFATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"ferrous sulfate","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"maltol","indication_name":"iron deficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Accrufer","generic_name":"MALTOL","company_name":"Shield Tx","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"deferoxamine","indication_name":"Chronic Iron Overload","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Desferal","generic_name":"DEFEROXAMINE","company_name":"Mitem Pharma","drug_phase":"marketed","molecular_target":"Deoxyhypusine hydroxylase","drug_class":"Iron Chelator","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"deferoxamine","indication_name":"Poisoning by iron AND/OR its compounds","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Desferal","generic_name":"DEFEROXAMINE","company_name":"Mitem Pharma","drug_phase":"marketed","molecular_target":"Deoxyhypusine hydroxylase","drug_class":"Iron Chelator","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"ferric-citrate","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Auryxia","generic_name":"FERRIC CITRATE","company_name":"Keryx Biopharms","drug_phase":"marketed","molecular_target":"","drug_class":"ferric citrate","quality_score":10,"revenue":null,"mechanism":"Auryxia works by binding to phosphate in the gut, reducing its absorption, and also providing iron to the body."},{"drug_id":"cyanocobalamin","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rubramin Pc","generic_name":"CYANOCOBALAMIN","company_name":"","drug_phase":"marketed","molecular_target":"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial","drug_class":"Vitamin C [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"docusate","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Colace","generic_name":"docusate sodium","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"N/A (surfactant mechanism)","drug_class":"Stool softener (surfactant laxative)","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"triferic","indication_name":"Iron supplement therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Triferic","company_name":"Rockwell Medical Technologies, Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"injectafer","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Injectafer","company_name":"United States Army Research Institute of Environmental Medicine","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":9,"revenue":null,"mechanism":null},{"drug_id":"ferric-carboxymaltose","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Injectafer","generic_name":"FERRIC CARBOXYMALTOSE","company_name":"Am Regent","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":44,"revenue":null,"mechanism":"Injectafer works by providing a rapid increase in iron levels in the body."},{"drug_id":"ferrous-gluconate","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Glucoferron","generic_name":"FERROUS GLUCONATE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"succinic-acid","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Butanedioic Acid","generic_name":"SUCCINIC ACID","company_name":"","drug_phase":"marketed","molecular_target":"Egl nine homolog 1","drug_class":"Vitamin C [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"hematin","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"hematin","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"hematin","quality_score":null,"revenue":null,"mechanism":"Hematin works by replenishing iron stores in the body, which is essential for the production of red blood cells."},{"drug_id":"cyanocobalamin-57co","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cyanocobalamin Co 57","generic_name":"cyanocobalamin (57Co)","company_name":"Mallinckrodt","drug_phase":"marketed","molecular_target":"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial, Methionine synthase, Methionine synthase reductase","drug_class":"Radioactive Diagnostic Agent","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"ferric-pyrophosphate-citrate","indication_name":"Iron supplement therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Triferic","generic_name":"FERRIC PYROPHOSPHATE CITRATE","company_name":"Rockwell Medical Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":""},{"drug_id":"ferumoxytol","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Feraheme","generic_name":"FERUMOXYTOL","company_name":"Covis","drug_phase":"marketed","molecular_target":"","drug_class":"Parenteral Iron Replacement [EPC]","quality_score":60,"revenue":null,"mechanism":"Feraheme delivers iron to macrophages where it is released and either stored or transported to erythroid precursor cells."},{"drug_id":"deferasirox","indication_name":"Chronic Iron Overload","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exjade","generic_name":"DEFERASIROX","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Flavin reductase (NADPH)","drug_class":"Iron Chelator [EPC]","quality_score":10,"revenue":null,"mechanism":"Exjade works by binding to iron in the body and removing it through the urine."},{"drug_id":"docusate-sodium","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Docusate","generic_name":"DOCUSATE SODIUM","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"docusate sodium","quality_score":null,"revenue":null,"mechanism":"Docusate sodium works by increasing the solubility of bile salts in the gut, allowing more water to be absorbed into the stool."},{"drug_id":"iron","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Elemental Iron (As Carbonyl Iron)","generic_name":"Iron","company_name":"Hippocration General Hospital","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ferric-derisomaltose","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monoferric","generic_name":"FERRIC DERISOMALTOSE","company_name":"Pharmacosmos","drug_phase":"marketed","molecular_target":"Serotransferrin","drug_class":"","quality_score":55,"revenue":null,"mechanism":"Monoferric works by binding to serotransferrin, a protein that transports iron in the body, allowing it to be absorbed and utilized by red blood cells."},{"drug_id":"deferiprone","indication_name":"Iron overload","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ferriprox","generic_name":"DEFERIPRONE","company_name":"Chiesi","drug_phase":"marketed","molecular_target":"Deoxyhypusine hydroxylase","drug_class":"Iron Chelator [EPC]","quality_score":75,"revenue":null,"mechanism":"Ferriprox works by binding to iron in the body and removing it, thereby reducing iron overload."},{"drug_id":"folic-acid","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Folic Acid","generic_name":"FOLIC ACID","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"Vitamin C [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"ferric-maltol","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Accrufer","generic_name":"FERRIC MALTOL","company_name":"Shield Tx","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ferinject","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ferinject","company_name":"Asan Medical Center","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"feraheme","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Feraheme","company_name":"University of Texas Southwestern Medical Center","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"desferrioxamine","indication_name":"Chronic Iron Overload","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"desferrioxamine","company_name":"Brigham and Women's Hospital","drug_phase":"phase_3","molecular_target":"Deoxyhypusine hydroxylase, Hypoxia-inducible factor 1-alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"desferrioxamine","indication_name":"Poisoning by iron AND/OR its compounds","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"desferrioxamine","company_name":"Brigham and Women's Hospital","drug_phase":"phase_3","molecular_target":"Deoxyhypusine hydroxylase, Hypoxia-inducible factor 1-alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"monoferric","indication_name":"Iron deficiency anemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Monoferric","company_name":"Brigham and Women's Hospital","drug_phase":"marketed","molecular_target":"Serotransferrin","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"chlorthalidone","indication_name":"Spironolactone in CKD enabled by chlorthalidone","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CHLORTHALIDONE","company_name":"","drug_phase":"marketed","molecular_target":"Na+/Cl− cotransporter","drug_class":"Thiazide-like Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":34,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT06371391","title":"Environmental and Occupational Noise Exposure in Relation to Incidence of Type 2 Diabetes","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03225586","title":"Prospective Urban Rural Epidemiology Study","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT07209774","title":"Healthspan Connect Programme of Research","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT07514377","title":"JiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in China","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"National Research Institute for Family Planning, China","has_results":false},{"nct_id":"NCT07119723","title":"Environmental Factors and Myopia Prevalence Among Uyghur Students in Remote China","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100000,"lead_sponsor_name":"Tianjin Medical University Eye Hospital","has_results":false},{"nct_id":"NCT00340860","title":"The Norwegian Mother and Child Study - Environmental Specimen Collection","phase":"","overall_status":"COMPLETED","enrollment_count":81093,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT06894095","title":"Dongzong Cardiovascular Bio-imaging Registry Study","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Jinling Hospital, China","has_results":false},{"nct_id":"NCT03276247","title":"Iron Status in Women of Reproductive Age Reproductive Age","phase":"","overall_status":"COMPLETED","enrollment_count":22042,"lead_sponsor_name":"Victor Gordeuk","has_results":false},{"nct_id":"NCT06781424","title":"University of Central Florida BEEAST","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University of Central Florida","has_results":false},{"nct_id":"NCT03845868","title":"Tongji-Ezhou Study","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06456320","title":"Mayo Clinic Tapestry 2.0: Applying Multi-Omics for Scientific Discovery","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05930626","title":"Biomarkers of Acrylamide, Glycidol, POPs, PFAS and Disease Outcomes and OMICs Signatures","phase":"","overall_status":"COMPLETED","enrollment_count":9254,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04155437","title":"Assessing the Feasibility of Integrating a Package of Maternal Nutrition Interventions Into Antenatal Care Services in Burkina Faso","phase":"NA","overall_status":"COMPLETED","enrollment_count":8110,"lead_sponsor_name":"International Food Policy Research Institute","has_results":false},{"nct_id":"NCT06879080","title":"Maternal Iron Deficiency and Childhood Health","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Tampere University Hospital","has_results":false},{"nct_id":"NCT03961074","title":"Iron Deficiency Anemia Among Chinese Pregnant Women: a Multi-center Prospective Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":5551,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT00001163","title":"Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5201,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07384676","title":"Environmental and Behavioral Factors in Infertility and ART Outcomes","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"The Third Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT03274726","title":"Iron Status of Women and Young Children in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Centers for Disease Control and Prevention","has_results":false},{"nct_id":"NCT05358509","title":"Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":4368,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT04125368","title":"A Feasibility Study of Integrating Maternal Nutrition Interventions Into Antenatal Care Services in Ethiopia","phase":"NA","overall_status":"COMPLETED","enrollment_count":4256,"lead_sponsor_name":"International Food Policy Research Institute","has_results":false},{"nct_id":"NCT05976126","title":"Characterization of a Population Living in Highly Contaminated Settlement in Campania Region","phase":"","overall_status":"COMPLETED","enrollment_count":4227,"lead_sponsor_name":"Francesca De Filippis","has_results":false},{"nct_id":"NCT00339274","title":"International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05893901","title":"Impact of Food-to-Food Fortified Cereal Products on Diet Quality in Rural Niger Villages","phase":"","overall_status":"COMPLETED","enrollment_count":3600,"lead_sponsor_name":"Purdue University","has_results":false},{"nct_id":"NCT05865782","title":"Reconstructing Schoolyards With Greenery to Increase Schoolchildren's Physical Activity and Mitigate Climate Changes","phase":"NA","overall_status":"RECRUITING","enrollment_count":3600,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03215368","title":"The Ma'Anshan Birth Cohort (MABC)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3474,"lead_sponsor_name":"Anhui Medical University","has_results":false},{"nct_id":"NCT03037931","title":"Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3065,"lead_sponsor_name":"American Regent, Inc.","has_results":true},{"nct_id":"NCT07467668","title":"Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT06115122","title":"PEPPI Study: Identification of Women at Risk for Placental Dysfunction","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Oulu University Hospital","has_results":false},{"nct_id":"NCT06200870","title":"ID as a Promoter of IH-induced CAVD","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT04817280","title":"COVID-19 in Polish Ice Swimmers.","phase":"","overall_status":"COMPLETED","enrollment_count":2534,"lead_sponsor_name":"Wroclaw Medical University","has_results":false},{"nct_id":"NCT03978260","title":"Preoperative Anaemia prevaLence In surgiCal patiEnts","phase":"","overall_status":"COMPLETED","enrollment_count":2500,"lead_sponsor_name":"Johann Wolfgang Goethe University Hospital","has_results":false},{"nct_id":"NCT05178407","title":"Effect of Household Use of Multiple Micronutrient-fortified Bouillon on Micronutrient Status Among Women and Children in Two Districts in the Northern Region of Ghana","phase":"NA","overall_status":"COMPLETED","enrollment_count":2372,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT03670927","title":"Etiosarc: Environmental Aetiology of Sarcomas From a Multicenter French Population-based Case-control Study Among Adults","phase":"","overall_status":"COMPLETED","enrollment_count":2237,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT03679000","title":"The Effect of Periconceptional Phthalates Exposure on Couples' Reproductive Health","phase":"","overall_status":"UNKNOWN","enrollment_count":2122,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT06810440","title":"Reducing Anemia Among Preconception Women in Nepal Through a Group Norm and Micronutrient Supplementation Intervention","phase":"NA","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT02694978","title":"A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2014,"lead_sponsor_name":"AMAG Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03713502","title":"Enteropathy and Diabetes in HIV Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":1947,"lead_sponsor_name":"National Institute for Medical Research, Tanzania","has_results":false},{"nct_id":"NCT06929806","title":"Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1900,"lead_sponsor_name":"Pharmacosmos A/S","has_results":false},{"nct_id":"NCT00327067","title":"Iron Replacement in Blood Donors","phase":"","overall_status":"COMPLETED","enrollment_count":1820,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT05872061","title":"Senegal Market Study for Food-to-Food Fortified (F2F) Instant Porridge Flours","phase":"","overall_status":"COMPLETED","enrollment_count":1800,"lead_sponsor_name":"Purdue University","has_results":false},{"nct_id":"NCT05882682","title":"Impact of Food-to-Food Fortified Cereal Products on Diet Quality in Eldoret, Kenya","phase":"","overall_status":"COMPLETED","enrollment_count":1800,"lead_sponsor_name":"Purdue University","has_results":false},{"nct_id":"NCT05725278","title":"Impact Evaluation of Triggerise's Tiko Platform","phase":"NA","overall_status":"COMPLETED","enrollment_count":1708,"lead_sponsor_name":"Network for Engineering and Economics Research and Management","has_results":false},{"nct_id":"NCT03915327","title":"Short-term Intravenous Iron Isomaltose Anhydride for IDA","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1600,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT05867836","title":"Multiple Micronutrient Supplementation vs Iron and Folic Acid Among Pregnant Women in Cambodia","phase":"NA","overall_status":"COMPLETED","enrollment_count":1545,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT02940860","title":"Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1538,"lead_sponsor_name":"Pharmacosmos A/S","has_results":true},{"nct_id":"NCT03749603","title":"A Study Assessing Iron Status and Anemia in Filipino School Children From MIMAROPA Region","phase":"NA","overall_status":"COMPLETED","enrollment_count":1521,"lead_sponsor_name":"Société des Produits Nestlé (SPN)","has_results":false},{"nct_id":"NCT02940886","title":"Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1512,"lead_sponsor_name":"Pharmacosmos A/S","has_results":true},{"nct_id":"NCT06408402","title":"Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1300,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04391517","title":"SpHb Perioperatively","phase":"NA","overall_status":"COMPLETED","enrollment_count":1284,"lead_sponsor_name":"Medical University of Graz","has_results":false},{"nct_id":"NCT03516734","title":"Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1252,"lead_sponsor_name":"Carol Henry","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}